Stuart W. Peltz's most recent trade in PTC Therapeutics Inc was a trade of 2,320 Common Stock done at an average price of $45.6 . Disclosure was reported to the exchange on Jan. 31, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 2,320 | 166,962 (0%) | 0% | 45.6 | 105,857 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 301 | 54,903 (0%) | 0% | 45.6 | 13,734 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.45 per share. | 24 Jan 2023 | 284 | 55,204 (0%) | 0% | 47.5 | 13,476 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 1,228 | 170,471 (0%) | 0% | 42.9 | 52,722 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 10 Jan 2023 | 1,189 | 169,282 (0%) | 0% | 44.4 | 52,744 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 571 | 55,980 (0%) | 0% | 42.9 | 24,515 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 10 Jan 2023 | 492 | 55,488 (0%) | 0% | 44.4 | 21,825 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 41.66 per share. | 09 Jan 2023 | 1,786 | 171,699 (0%) | 0% | 41.7 | 74,398 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 41.66 per share. | 09 Jan 2023 | 279 | 56,551 (0%) | 0% | 41.7 | 11,622 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 132,500 | 132,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 53,000 | 173,485 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 18,000 | 56,830 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.83 per share. | 07 Jun 2022 | 407 | 38,239 (0%) | 0% | 26.8 | 10,919 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.28 per share. | 14 Apr 2022 | 82 | 38,646 (0%) | 0% | 45.3 | 3,713 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 1,961 | 120,485 (0%) | 0% | 40.0 | 78,444 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 282 | 38,728 (0%) | 0% | 40.0 | 11,281 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.32 per share. | 25 Jan 2022 | 330 | 39,010 (0%) | 0% | 39.3 | 12,974 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 165,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 44,000 | 122,446 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 16,800 | 39,340 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.52 per share. | 07 Jan 2022 | 1,869 | 78,446 (0%) | 0% | 38.5 | 72,003 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.52 per share. | 07 Jan 2022 | 294 | 22,540 (0%) | 0% | 38.5 | 11,326 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.16 per share. | 04 Jan 2022 | 378 | 22,834 (0%) | 0% | 41.2 | 15,559 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 36,400 | 36,400 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 6,240 | 22,721 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2021 | 1,400 | 16,481 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.96 per share. | 01 Feb 2021 | 1,968 | 80,315 (0%) | 0% | 57.0 | 112,089 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.96 per share. | 01 Feb 2021 | 283 | 15,081 (0%) | 0% | 57.0 | 16,119 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.05 per share. | 25 Jan 2021 | 350 | 15,364 (0%) | 0% | 62.1 | 21,719 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 161,000 | 161,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 27,600 | 82,283 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 23,100 | 23,100 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 3,960 | 15,714 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 05 Jan 2021 | 1,402 | 54,683 (0%) | 0% | 62.4 | 87,443 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 05 Jan 2021 | 382 | 11,754 (0%) | 0% | 62.4 | 23,825 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 05 Jan 2021 | 284 | 12,136 (0%) | 0% | 62.4 | 17,713 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 30 Dec 2020 | 169,781 | 225,866 (0%) | 0% | 30.9 | 5,239,442 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2020 | 169,781 | 5,219 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.43 per share. | 30 Dec 2020 | 122,790 | 103,076 (0%) | 0% | 61.4 | 7,543,358 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 30 Dec 2020 | 115,937 | 172,022 (0%) | 0% | 33.0 | 3,828,240 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2020 | 115,937 | 149,063 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.43 per share. | 30 Dec 2020 | 77,939 | 94,083 (0%) | 0% | 61.4 | 4,787,793 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.34 per share. | 30 Dec 2020 | 38,779 | 64,297 (0%) | 0% | 62.3 | 2,417,560 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.27 per share. | 30 Dec 2020 | 30,060 | 64,023 (0%) | 0% | 62.3 | 1,871,776 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.19 per share. | 30 Dec 2020 | 8,212 | 56,085 (0%) | 0% | 63.2 | 518,924 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.25 per share. | 30 Dec 2020 | 7,938 | 56,085 (0%) | 0% | 63.2 | 502,047 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.05 per share. | 07 Dec 2020 | 192,792 | 248,877 (0%) | 0% | 27.1 | 5,215,024 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 192,792 | 0 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 137,500 | 62,500 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 07 Dec 2020 | 137,500 | 193,585 (0%) | 0% | 18.0 | 2,476,375 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.56 per share. | 07 Dec 2020 | 85,113 | 163,764 (0%) | 0% | 59.6 | 5,068,990 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.56 per share. | 07 Dec 2020 | 61,768 | 131,817 (0%) | 0% | 59.6 | 3,678,902 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.64 per share. | 07 Dec 2020 | 34,036 | 129,728 (0%) | 0% | 60.6 | 2,063,807 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.68 per share. | 07 Dec 2020 | 33,443 | 96,285 (0%) | 0% | 61.7 | 2,062,764 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.68 per share. | 07 Dec 2020 | 23,543 | 85,372 (0%) | 0% | 61.7 | 1,452,038 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.66 per share. | 07 Dec 2020 | 22,902 | 108,915 (0%) | 0% | 60.7 | 1,389,281 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 07 Dec 2020 | 18,125 | 74,210 (0%) | 0% | 11.2 | 203,544 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 18,125 | 7,875 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.63 per share. | 07 Dec 2020 | 18,022 | 57,785 (0%) | 0% | 64.6 | 1,164,672 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.43 per share. | 07 Dec 2020 | 13,984 | 82,301 (0%) | 0% | 62.4 | 873,091 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.61 per share. | 07 Dec 2020 | 13,530 | 56,395 (0%) | 0% | 64.6 | 874,133 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.41 per share. | 07 Dec 2020 | 9,927 | 75,445 (0%) | 0% | 62.4 | 619,574 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.58 per share. | 07 Dec 2020 | 7,652 | 66,558 (0%) | 0% | 59.6 | 455,906 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 7,590 | 3,104 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 07 Dec 2020 | 7,590 | 63,675 (0%) | 0% | 10.9 | 82,352 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 7,208 | 192,792 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.05 per share. | 07 Dec 2020 | 7,208 | 63,293 (0%) | 0% | 27.0 | 194,976 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.67 per share. | 07 Dec 2020 | 6,494 | 75,807 (0%) | 0% | 63.7 | 413,499 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.65 per share. | 07 Dec 2020 | 5,520 | 69,925 (0%) | 0% | 63.7 | 351,359 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.84 per share. | 07 Dec 2020 | 3,332 | 63,226 (0%) | 0% | 60.8 | 202,726 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.36 per share. | 07 Dec 2020 | 3,242 | 56,385 (0%) | 0% | 64.4 | 208,665 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 3,104 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 07 Dec 2020 | 3,104 | 59,189 (0%) | 0% | 10.8 | 33,678 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.56 per share. | 07 Dec 2020 | 3,090 | 60,585 (0%) | 0% | 59.6 | 184,037 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.90 per share. | 07 Dec 2020 | 2,852 | 60,374 (0%) | 0% | 61.9 | 176,547 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.57 per share. | 07 Dec 2020 | 2,808 | 60,485 (0%) | 0% | 59.6 | 167,259 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 2,115 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 07 Dec 2020 | 2,115 | 58,200 (0%) | 0% | 10.9 | 22,948 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.78 per share. | 07 Dec 2020 | 1,700 | 56,085 (0%) | 0% | 65.8 | 111,818 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.41 per share. | 07 Dec 2020 | 1,600 | 56,185 (0%) | 0% | 64.4 | 103,051 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.83 per share. | 07 Dec 2020 | 1,300 | 58,085 (0%) | 0% | 61.8 | 80,375 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.52 per share. | 07 Dec 2020 | 1,255 | 57,934 (0%) | 0% | 59.5 | 74,694 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.16 per share. | 07 Dec 2020 | 1,200 | 56,785 (0%) | 0% | 64.2 | 76,992 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.93 per share. | 07 Dec 2020 | 1,200 | 58,185 (0%) | 0% | 61.9 | 74,312 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.87 per share. | 07 Dec 2020 | 1,200 | 59,385 (0%) | 0% | 60.9 | 73,042 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.72 per share. | 07 Dec 2020 | 1,100 | 59,385 (0%) | 0% | 60.7 | 66,796 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.52 per share. | 07 Dec 2020 | 815 | 57,385 (0%) | 0% | 59.5 | 48,505 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.01 per share. | 07 Dec 2020 | 747 | 59,627 (0%) | 0% | 63.0 | 47,068 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.82 per share. | 07 Dec 2020 | 700 | 56,085 (0%) | 0% | 64.8 | 45,374 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.95 per share. | 07 Dec 2020 | 600 | 57,334 (0%) | 0% | 60.9 | 36,569 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.01 per share. | 07 Dec 2020 | 500 | 56,385 (0%) | 0% | 64.0 | 32,005 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.42 per share. | 07 Dec 2020 | 500 | 56,085 (0%) | 0% | 64.4 | 32,210 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.88 per share. | 07 Dec 2020 | 449 | 56,885 (0%) | 0% | 61.9 | 27,782 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.88 per share. | 07 Dec 2020 | 400 | 56,585 (0%) | 0% | 61.9 | 24,754 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.68 per share. | 07 Dec 2020 | 400 | 56,985 (0%) | 0% | 60.7 | 24,272 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.21 per share. | 07 Dec 2020 | 400 | 57,785 (0%) | 0% | 63.2 | 25,284 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.71 per share. | 07 Dec 2020 | 310 | 56,085 (0%) | 0% | 65.7 | 20,369 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.71 per share. | 07 Dec 2020 | 300 | 56,085 (0%) | 0% | 64.7 | 19,412 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.19 per share. | 07 Dec 2020 | 300 | 56,085 (0%) | 0% | 65.2 | 19,558 | Common Stock |